Genus plc’s Buy Rating Reaffirmed at Liberum Capital (GNS)
Genus plc (LON:GNS)‘s stock had its “buy” rating restated by stock analysts at Liberum Capital in a report issued on Wednesday. They currently have a GBX 1,400 ($23.23) price target on the stock. Liberum Capital’s price objective indicates a potential upside of 23.35% from the company’s current price.
Shares of Genus plc (LON:GNS) opened at 1147.00 on Wednesday. Genus plc has a one year low of GBX 924.50 and a one year high of GBX 1453.00. The stock’s 50-day moving average is GBX 1074. and its 200-day moving average is GBX 1071.. The company’s market cap is £693.9 million.
Several other analysts have also recently commented on the stock. Analysts at Numis Securities Ltd initiated coverage on shares of Genus plc in a research note on Thursday, August 21st. They set an “add” rating and a GBX 1,290 ($21.41) price target on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Friday, June 6th. They now have a GBX 1,000 ($16.59) price target on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 1,312.86 ($21.79).
Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with Analyst Ratings Network's FREE daily email newsletter.